Stock News | KlickAnalytics

Markets Tools AI Stocks Funds Newsroom Economy Commodities FX Crypto My Symbol Resources

Market News Stock News Categories Social Sentiments Market TV Press Releases

Company	Headline	Time (ET)
CLMT	Verifying Calumet Specialty Products' New Trajectory	07/07 05:24
NBIS	Nebius: Staying Positive Despite Recent Weakness	07/07 05:20
ANRGF	Anaergia Australia Pty Ltd. to Supply Advanced Anaerobic Digestion Technology for Goodness Grown Facility in Australia	07/07 05:20
SSNLF	Tough crowd for Samsung as record quarterly earnings brings out the sellers	07/07 05:18
NVDA	Nvidia-Backed Startup Nscale Locks in $900 Million for Data-Center Buildout	07/07 05:16
RNMBF	Lockheed Martin and Rheinmetall Move Forward with ATACMS Co-Production in Europe	07/07 05:15
PLTR	AI Leaders Nvidia, Palantir, and Meta Platforms Are Shaking Wall Street's Foundation With This $15.6 Billion Warning	07/07 05:06
ALVOF	Strength Seen in Alvopetro Energy (ALVOF): Can Its 7.4% Jump Turn into More Strength?	07/07 05:05
PODD	PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm	07/07 05:05
SPCX	The SpaceX Sell-Off Looks to Be Getting Worse. Here's What Patient Investors Should Do Right Now.	07/07 05:05
JVA	Black Rock Coffee Bar, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BRCB	07/07 05:03
FSLR	First Solar, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FSLR	07/07 05:02
GEMI	Gemini Space Station, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GEMI	07/07 05:01
MA	Mastercard: This Has Already Mastered Evolving And Navigating A Fast-Paced Landscape	07/07 05:00
TAL	TAL Education Group to Announce First Quarter of Fiscal Year 2027 Financial Results on July 30, 2026	07/07 05:00
BUR	New Research from Burford Capital and The Lawyer: Two-Thirds of Lawyers Say Strong Claims Go Unpursued Because of Cost	07/07 05:00
ITM	ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs	07/07 05:00